[1] COBURN N,COSBY R,KLEIN L,et al. Staging and surgical approaches in gastric cancer:A systematic review[J]. Cancer Treat Rev,2018,63(3):104-115. [2] BATLLE E,CLEVERS H. Cancer stem cells revisited[J]. Nat Med,2017,23(10):1124-1134. [3] BAKHSHINYAN D,ADILE A A,QAZI M A,et al. Introduction to cancer stem cells:Past,present,and future[J]. Methods Mol Biol,2018,1692(1):1-16. [4] REGENBRECHT C R,LEHRACH H,ADJAYE J. Stemming cancer:functional genomics of cancer stem cells in solid tumors[J]. Stem Cell Rev,2008,4(4):319-328. [5] SAIKAWA Y,FUKUDA K,TAKAHASHI T,et al. Gastric carcinogenesis and the cancer stem cell hypothesis[J]. Gastric Cancer,2010,13(1):11-24. [6] HOUGHTON J,STOICOV C,NOMURA S,et al. Gastric cancer originating from bone marrow-derived cells[J]. Science,2004,306(5701):1568-1571. [7] BJERKVIG R,TYSNES B B,ABOODY K S,et al. Opinion:The origin of the cancer stem cell:current controversies and new insights[J]. Nat Rev Cancer,2005,5(11):899-904. [8] SINGH M,YELLE N,VENUGOPAL C,et al. EMT:Mechanisms and therapeutic implications[J]. Pharmacol Ther,2018,182(1):80-94. [9] JIE X X,ZHANG X Y,XU C J. Epithelial-to-mesenchymal transition,circulating tumor cells and cancer metastasis:Mechanisms and clinical applications[J]. Oncotarget,2017,8(46):81558-81571. [10] KURREY N K,JALGAONKAR S P,JOGLEKAR A V,et al. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells[J]. Stem Cells,2009,27(9):2059-2068. [11] YANG L,PING Y F,YU X,et al. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype[J]. Cancer Lett,2011,310(1):46-52. [12] ABBASZADEGAN M R,BAGHERI V,RAZAVI M S,et al. Isolation,identification,and characterization of cancer stem cells:A review[J]. J Cell Physiol,2017,232(8):2008-2018. [13] CHEN T,YANG K,YU J,et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients[J]. Cell Res,2012,22(1):248-258. [14] YOON C,DO PARK J,SCHMIDT B,et al. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance[J]. Clin Cancer Res,2014,20(15):3974-3988. [15] ZHU Y,YU J,WANG S,et al. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells[J]. Oncol Rep,2014,32(6):2437-2444. [16] NISHIKAWA S,KONNO M,HAMABE A,et al. Aldehyde dehydro-genase high gastric cancer stem cells are resistant to chemotherapy[J]. Int J Oncol,2013,42(4):1437-1442. [17] IMANO M,ITOH T,SATOU T,et al. High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer[J]. Target Oncol,2013,8(4):231-235. [18] JIANG J,ZHANG Y,CHUAI S,et al. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype[J]. Oncogene,2012,31(6):671-682. [19] LAU W M,TENG E,CHONG H S,et al. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells[J]. Cancer Res,2014,74(9):2630-2641. [20] HARAGUCHI N,INOUE H,TANAKA F,et al. Cancer stem cells in human gastrointestinal cancers[J]. Hum Cell,2006,19(1):24-29. [21] SCHMUCK R,WARNEKE V,BEHRENS H M,et al. Genotypic and phenotypic characterization of side population of gastric cancer cell lines[J]. Am J Pathol,2011,178(4):1792-1804. [22] ZHOU Y L,LI Y M,HE W T. Application of mesenchymal stem cells in the targeted gene therapy for gastric cancer[J]. Curr Stem Cell Res Ther,2016,11(5):434-439. [23] SUN H,ZU Y. A highlight of recent advances in aptamer technology and its application[J]. Molecules,2015,20(7):11959-11980. [24] SHIGDAR S,LIN J,YU Y,et al. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule[J]. Cancer Sci,2011,102(5):991-998. [25] SMITH L M,NESTEROVA A,RYAN M C,et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers[J]. Br J Cancer,2008,99(1):100-109. [26] JIANG J,ZHANG Y,CHUAI S,et al. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype[J]. Oncogene,2012,31(6):671-682. [27] CHEREPANOV S A,GRINENKO N F,ANTONOVA O M,et al. Relationship between Hedgehog signaling pathway and drug resistance of poorly differentiated gliomas[J]. Bull Exp Biol Med,2018,164(3):356-361. [28] SONG Z,YUE W,WEI B,et al. Sonic Hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer[J]. PLoS One,2011,6(3):e17687. [29] STANTON B Z,PENG L F,MALOOF N,et al. A small molecule that binds Hedgehog and blocks its signaling in human cells[J]. Nat Chem Biol,2009,5(3):154-156. [30] BRAHMI M,BALLY O,EBERST L,et al. Therapeutic targeting of Notch signaling in cancer[J]. Bull Cancer,2017,104(10):883-891. [31] PIAZZI G,FINI L,SELGRAD M,et al. Epigenetic regulation of Delta-like1 controls Notch1 activation in gastric cancer[J]. Oncotarget,2011,2(12):1291-1301. [32] SARMANTO L M,BARATA J T. Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia:rationale,caveats and promises[J]. Expert Rev Anticancer Ther,2011,11(9):1403-1415. [33] MAO J,FAN S,MA W,et al. Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment[J]. Cell Death Dis,2014,5(1):e1039. [34] LEE S Y,SAITO T,MITOMI H,et al. Mutation spectrum in the Wnt/β-catenin signaling pathway in gastric fundic gland-associated neoplasms/polyps[J]. Virchows Arch,2015,467(1):27-38. [35] FAN D,REN B,YANG X,et al. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer[J]. J Exp Clin Cancer Res,2016,35(1):177. [36] KIM K Y,PARK K I,KIM S H,et al. Salinomycin induces reactive oxygen species and apoptosis in aggressive breast cancer cells as mediated with regulation of autophagy[J]. Anticancer Res,2017,37(4):1747-1758. [37] ZHI Q M,CHEN X H,JI J,et al. Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer[J]. Biomed Pharma-cother,2011,65(7):509-515. [38] XU Y,HE K,GOLDKORN A. Telomerase targeted therapy in cancer and cancer stem cells[J]. Clin Adv Hematol Oncol,2011,9(6):442-455. [39] ZHANG H,YANG M H,ZHAO J J,et al. Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors[J]. Oncol Rep,2010,24(4):1059-1065. |